title: Recent Advances in Hydrocortisone Replacement Treatment.
abstract: Since the first use of cortisone in patients around 65 years ago, the use of synthetic glucocorticoids has made a crucial impact on the treatment of several diseases in medicine. Although significant reductions in morbidity and mortality have occurred in patients suffering from cortisol deficiency, conventional hydrocortisone replacement treatment is still inadequate. A major limitation is that it fails to replace cortisol in a physiological manner. Cortisol has a distinct circadian rhythm and acts as a secondary messenger synchronizing the central to peripheral clocks, hence playing a key role in biological processes and the circadian timing system. Circadian misalignment has been associated with ill-health and so nonphysiological glucocorticoid treatment could explain the increased mortality rate, poor quality of life and metabolic complications in patients suffering from adrenal insufficiency. Attempts at replacing cortisol in a physiological manner have shown significant progress in the past decade with the development of modified-release formulations of hydrocortisone (Chronocort® and Plenadren®) and continuous subcutaneous hydrocortisone infusions. Initial studies investigating the use of these replacement regimens are promising, demonstrating both clinical and biochemical improvement. Larger studies are needed to determine whether this novel approach enhances long-term outcomes in both children and adults with cortisol deficiency. This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. Published by S. Karger AG, Basel.
authors.forename: Ashwini
authors.initials: A
authors.lastname: Mallappa
authors.forename: Miguel
authors.initials: M
authors.lastname: Debono
mesh_terms: D002940:Circadian Rhythm / Q000502:physiology*; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000172:deficiency* / Q000494:pharmacology; D020249:Hormone Replacement Therapy / Q000379:methods* / Q000639:trends; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage* / Q000172:deficiency* / Q000494:pharmacology
chemical_list: D005938:Glucocorticoids; D006854:Hydrocortisone